He was the lead investigator in a study published in the May/June 2022 issue of JCOM that found that, when allocated to the appropriate patient type, intravenous immunoglobulin can reduce hospital costs for COVID-19 care.

The goal of this activity is to improve healthcare providers' knowledge on the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI) in the outpatient setting as well as how to best incorporate novel antimicrobials into patient care plans. LEARNING OBJECTIVESAfter participating in the activity, healthcare providers will: Have increased knowledge regarding the • Identi cation of patients who can be treated for ABSSSI in the outpatient setting • Latest data on new oral antibiotics used in the treatment of ABSSSI Have greater competence related to • Determining a patient care strategy for ABSSSI in the community TARGET AUDIENCEThis activity is intended for primary care physicians, infectious disease specialists, emergency medicine physicians, nurses, nurse practitioners, and physician assistants.